These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 17393088)

  • 21. Human thyroxine-binding globulin gene: complete sequence and transcriptional regulation.
    Hayashi Y; Mori Y; Janssen OE; Sunthornthepvarakul T; Weiss RE; Takeda K; Weinberg M; Seo H; Bell GI; Refetoff S
    Mol Endocrinol; 1993 Aug; 7(8):1049-60. PubMed ID: 8232304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of hepatitis-B-virus core promoter by p53: implications for carcinogenesis in hepatocytes.
    Uchida T; Takahashi K; Tatsuno K; Dhingra U; Eliason JF
    Int J Cancer; 1996 Sep; 67(6):892-7. PubMed ID: 8824564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Transcriptional inhibitory effect of hepatitis B virus X protein on the expression of p53 tumor suppression gene].
    Li J; Liu Y; Dai JZ; Xu DP; Zhang LX
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Mar; 20(1):26-9. PubMed ID: 16642213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p53-dependent suppression of uridine phosphorylase gene expression through direct promoter interaction.
    Zhang D; Cao D; Russell R; Pizzorno G
    Cancer Res; 2001 Sep; 61(18):6899-905. PubMed ID: 11559567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. All-trans retinoic acid induces XAF1 expression through an interferon regulatory factor-1 element in colon cancer.
    Wang J; Peng Y; Sun YW; He H; Zhu S; An X; Li M; Lin MC; Zou B; Xia HH; Jiang B; Chan AO; Yuen MF; Kung HF; Wong BC
    Gastroenterology; 2006 Mar; 130(3):747-58. PubMed ID: 16530516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cloning and characterization of the mouse JDP2 gene promoter reveal negative regulation by p53.
    Xu Y; Jin C; Liu Z; Pan J; Li H; Zhang Z; Bi S; Yokoyama KK
    Biochem Biophys Res Commun; 2014 Aug; 450(4):1531-6. PubMed ID: 25026555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of PRC1 as the p53 target gene uncovers a novel function of p53 in the regulation of cytokinesis.
    Li C; Lin M; Liu J
    Oncogene; 2004 Dec; 23(58):9336-47. PubMed ID: 15531928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway.
    Mirza A; McGuirk M; Hockenberry TN; Wu Q; Ashar H; Black S; Wen SF; Wang L; Kirschmeier P; Bishop WR; Nielsen LL; Pickett CB; Liu S
    Oncogene; 2002 Apr; 21(17):2613-22. PubMed ID: 11965534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The expression of the P2Y
    Molle CM; Arguin G; Jemfer C; Placet M; Dagenais Bellefeuille S; Gendron FP
    Biochem Biophys Res Commun; 2020 Apr; 524(4):798-802. PubMed ID: 32037085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptional suppression of multidrug resistance-associated protein (MRP) gene expression by wild-type p53.
    Wang Q; Beck WT
    Cancer Res; 1998 Dec; 58(24):5762-9. PubMed ID: 9865734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The mouse chemerin receptor gene, mcmklr1, utilizes alternative promoters for transcription and is regulated by all-trans retinoic acid.
    Mårtensson UE; Bristulf J; Owman C; Olde B
    Gene; 2005 Apr; 350(1):65-77. PubMed ID: 15792532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53 negatively regulates the expression of FAT10, a gene upregulated in various cancers.
    Zhang DW; Jeang KT; Lee CG
    Oncogene; 2006 Apr; 25(16):2318-27. PubMed ID: 16501612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a p53-dependent negative response element in the bcl-2 gene.
    Miyashita T; Harigai M; Hanada M; Reed JC
    Cancer Res; 1994 Jun; 54(12):3131-5. PubMed ID: 8205530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Interaction of p53 with p53 response element like binding sequence at upstream of hepatitis B virus enhancer I].
    Qu JH; Zhu MH; Lin J; Ni CR; Li FM; Zhu Z; Yu GZ
    Ai Zheng; 2004 May; 23(5):502-7. PubMed ID: 15142443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth factor-dependent regulation of survivin by c-myc in human breast cancer.
    Cosgrave N; Hill AD; Young LS
    J Mol Endocrinol; 2006 Dec; 37(3):377-90. PubMed ID: 17170079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.
    Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM
    Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of p53 transactivation through high-affinity binding sites.
    Chumakov AM; Miller CW; Chen DL; Koeffler HP
    Oncogene; 1993 Nov; 8(11):3005-11. PubMed ID: 8414502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Restin protein expression in non-small cell lung cancer.
    Nana FA; Lamberts V; Hoton D; Stanciu CP; Lecocq M; Carlier FM; Duplaquet F; Pirard L; Pilette C; Bihin B; Ocak S
    Thorac Cancer; 2023 Aug; 14(23):2302-2309. PubMed ID: 37365889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell-cycle regulation of the p53-inducible gene B99.
    Collavin L; Monte M; Verardo R; Pfleger C; Schneider C
    FEBS Lett; 2000 Sep; 481(1):57-62. PubMed ID: 10984615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A/T gap tolerance in the core sequence and flanking sequence requirements of non-canonical p53 response elements.
    Cai BH; Chao CF; Lin HC; Huang HY; Kannagi R; Chen JY
    J Biochem; 2016 Jun; 159(6):563-72. PubMed ID: 26823482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.